PURPOSE: To evaluate the foregut and hindgut hypotheses for metabolic surgery in obese rats with diabetes. METHODS: Otsuka Long-Evans Tokushima fatty rats were divided into a sham operation group, a partial duodeno-jejunal bypass (P-DJB) group, and a complete DJB (C-DJB) group. P-DJB is a model to test foregut hypothesis, whereas C-DJB is a model to test both hypotheses. We performed oral glucose tolerance tests (OGTT) on all groups at baseline, and then 4 and 8 weeks postoperatively. The rats were killed thereafter and the plasma levels of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) were measured. A separate sub-group of C-DJB rats underwent OGTT after treatment with the GLP-1 antagonist, the PYY antagonist, or saline. RESULTS: Marked improvement of the blood glucose control during the OGTT was noted 8 weeks after C-DJB, but not 8 weeks after P-DJB or the sham operation. The serum GLP-1 and PYY levels were higher in the C-DJB group than in the other two groups. Pretreatment with the GLP-1 antagonist increased the blood glucose levels 30 min after the OGTT in the C-DJB rats. CONCLUSIONS: Improvement in glucose metabolism after DJB was associated with the inflow of bile and pancreatic juice into the ileum, supporting validity of the hindgut hypothesis. GLP-1 appears to play a role in this improvement.
PURPOSE: To evaluate the foregut and hindgut hypotheses for metabolic surgery in obeserats with diabetes. METHODS:Otsuka Long-Evans Tokushima fattyrats were divided into a sham operation group, a partial duodeno-jejunal bypass (P-DJB) group, and a complete DJB (C-DJB) group. P-DJB is a model to test foregut hypothesis, whereas C-DJB is a model to test both hypotheses. We performed oral glucose tolerance tests (OGTT) on all groups at baseline, and then 4 and 8 weeks postoperatively. The rats were killed thereafter and the plasma levels of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) were measured. A separate sub-group of C-DJB rats underwent OGTT after treatment with the GLP-1 antagonist, the PYY antagonist, or saline. RESULTS: Marked improvement of the blood glucose control during the OGTT was noted 8 weeks after C-DJB, but not 8 weeks after P-DJB or the sham operation. The serum GLP-1 and PYY levels were higher in the C-DJB group than in the other two groups. Pretreatment with the GLP-1 antagonist increased the blood glucose levels 30 min after the OGTT in the C-DJB rats. CONCLUSIONS: Improvement in glucose metabolism after DJB was associated with the inflow of bile and pancreatic juice into the ileum, supporting validity of the hindgut hypothesis. GLP-1 appears to play a role in this improvement.
Authors: R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-02-24 Impact factor: 4.052
Authors: Aureo Ludovico De Paula; Alessandro R Stival; Alfredo Halpern; Carolina C L DePaula; Andrea Mari; Elza Muscelli; Sergio Vencio; Ele Ferrannini Journal: J Gastrointest Surg Date: 2011-05-10 Impact factor: 3.452
Authors: Bethany P Cummings; April D Strader; Kimber L Stanhope; James L Graham; Jennifer Lee; Helen E Raybould; Denis G Baskin; Peter J Havel Journal: Gastroenterology Date: 2010-03-10 Impact factor: 22.682
Authors: Ruben Schouten; Carianne S Rijs; Nicole D Bouvy; Wim Hameeteman; Ger H Koek; Ignace M C Janssen; Jan-Willem M Greve Journal: Ann Surg Date: 2010-02 Impact factor: 12.969
Authors: Alberto Patriti; Maria Cristina Aisa; Claudia Annetti; Angelo Sidoni; Francesco Galli; Ivana Ferri; Nino Gullà; Annibale Donini Journal: Surgery Date: 2007-07 Impact factor: 3.982